JGC
MDT icon

J. Goldman & Co’s Medtronic MDT Stock Holding History

J. Goldman & Co’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-2,300
Closed -$166K – 292
2014
Q4 		$166K Hold
2,300
– – 0.02% 173
2014
Q3 		$142K Buy
+2,300
New +$146K 0.01% 267

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

J. Goldman & Co's MDT Position: Q1 2026 in Review

J. Goldman & Co opened a new position in Medtronic (MDT) in Q1 2026: 2,392 shares worth $207K. The stake represents 0.01% of the portfolio and ranks #598 among its holdings. This is a return to the name: J. Goldman & Co previously reported a position in MDT as recently as Q1 2016.

J. Goldman & Co first reported a position in MDT in Q3 2013 and has held it in 6 quarters since. The position peaked at $12.7M in Q4 2013. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • J. Goldman & Co held 2,392 shares of Medtronic worth $207K as of Q1 2026.
  • Medtronic was a new J. Goldman & Co position in Q1 2026.
  • Medtronic made up 0.01% of J. Goldman & Co's portfolio in Q1 2026, its #598 holding.
  • J. Goldman & Co first reported a position in Medtronic in Q3 2013 and has held it in 6 quarters since.
  • J. Goldman & Co's Medtronic position peaked at $12.7M in Q4 2013.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on J. Goldman & Co's 13F filing for Q1 2026, filed 15 May 2026.